Seeker Labs Welcomes BlueRock Therapeutics as Anchor Tenant at New Catalyst Facility

Seeker Labs proudly announced a significant milestone in Toronto's life sciences landscape with BlueRock Therapeutics signing a long-term lease for approximately 80,000 square feet at Catalyst, a state-of-the-art facility located at 77 Wade Avenue in the Junction neighborhood. This development marks a pivotal moment not only for Seeker Labs but also for Toronto's burgeoning life sciences sector.

Catalyst, which spans a total of 155,000 square feet, has been meticulously engineered to support advanced laboratory and research uses, suitable for activities such as wet lab and clinical research operations. As the first privately funded, purpose-built life sciences facility to be completed in Toronto in over two decades, Catalyst stands as a testament to the growing demand for institutional-grade infrastructure in the region.

Cary Solomon, Managing Partner of Seeker Labs, expressed enthusiastic support for this collaboration, stating, "We are pleased to welcome BlueRock Therapeutics to Catalyst. Their commitment reflects the quality of the facility and underscores the ongoing demand for high-caliber life sciences infrastructure here in Toronto."

Since its inception in 2016, BlueRock Therapeutics has operated its R&D and manufacturing efforts within Toronto, growing to become a wholly owned subsidiary of Bayer AG. The company focuses on pioneering cell therapies aimed at treating degenerative diseases, and its decision to customize its premises at Catalyst will enhance its ongoing research, clinical development, and manufacturing processes.

Catalyst has been designed with the operational needs of leading life sciences organizations in mind, featuring infrastructure that is specifically tailored for advanced laboratory environments and scalable research operations.

The announcement regarding BlueRock's lease illuminates the rapid expansion occurring within Canada’s life sciences sector and highlights the increasing need for specialized research facilities in the Greater Toronto Area. Seeker Labs is proactive in addressing these needs, with additional projects planned across the country in its broader national life sciences strategy.

This partnership between Seeker Labs and BlueRock Therapeutics stands as a vital step in promoting innovation and research within the life sciences, not just within Toronto but throughout Canada. As the industry continues to grow, the collaborative efforts between such companies will play a crucial role in the evolution of medical advancements and treatments.

For more information about Seeker Labs and their innovative developments in the life sciences space, please visit SeekerLabs.ca.

About Seeker Labs

Seeker Labs is a Toronto-based platform dedicated to real estate development and management, focusing primarily on creating infrastructure for innovation and life sciences across Canada. The team's expertise spans over 35 years in various development projects throughout Canada and the United States, contributing to more than 12 million square feet of successful developments and redevelopments.